File Download
There are no files associated with this item.
Links for fulltext
(May Require Subscription)
- Publisher Website: 10.1002/chem.201000167
- Scopus: eid_2-s2.0-77953563443
- PMID: 20437426
- WOS: WOS:000279856100023
- Find via
Supplementary
-
Bookmarks:
- CiteULike: 2
- Citations:
- Appears in Collections:
Article: Structure-based design of platinum(II) Complexes as c-myc oncogene Down-regulators and luminescent probes for G-quadruplex DNA
Title | Structure-based design of platinum(II) Complexes as c-myc oncogene Down-regulators and luminescent probes for G-quadruplex DNA | ||||||||
---|---|---|---|---|---|---|---|---|---|
Authors | |||||||||
Keywords | DNA structures Gquadruplexes Ligand effects Oncogenes Platinum | ||||||||
Issue Date | 2010 | ||||||||
Publisher | Wiley - V C H Verlag GmbH & Co KGaA. The Journal's web site is located at http://www.wiley-vch.de/home/chemistry | ||||||||
Citation | Chemistry - A European Journal, 2010, v. 16 n. 23, p. 6900-6911 How to Cite? | ||||||||
Abstract | A series of platinum(II) complexes with tridentate ligands was synthesized and their interactions with Gquadruplex DNA within the c-myc gene promoter were evaluated. Complex 1, which has a flat planar 2,6-bis(benzimidazol-2-yl)pyridine (bzimpy) scaffold, was found to stabilize the c-myc G-quadruplex structure in a cellfree system. An in silico G-quadruplex DNA model has been constructed for structure-based virtual screening to develop new PtII-based complexes with superior inhibitory activities. By using complex 1 as the initial structure for hit-to-lead optimization, bzimpy and related 2,6-bis(pyrazol-3-yl) pyridine (dPzPy) scaffolds containing amine side-chains emerge as the top candidates. Six of the top-scoring complexes were synthesized and their interactions with c-myc G-quadruplex DNA have been investigated. The results revealed that all of the complexes have the ability to stabilize the c-myc G-quadruplex. Complex 3a ([PtIIL2R]+; L2 = 2,6bis[1-(3-piperidinepropyl)-1H-enzo[d]imidazol-2-yl]pyridine, R = Cl) displayed the strongest inhibition in a cell-free system (IC50 = 2.2 μM) and was 3.3-fold more potent than that of 1. Complexes 3a and 4a ([PtIIL3R]+; L3 = 2,6-bis[1-(3-morpholinopropyl)1H- pyrazol-3-yl]pyridine, R = Cl) were found to effectively inhibit c-myc gene expression in human hepatocarcinoma cells with IC50 values of 17 μM, whereas initial hit 1 displayed no significant effect on gene expression at concentrations up to 50 μM. Complexes 3a and 4a have a strong preference for Gquadruplex DNA over duplex DNA, as revealed by competition dialysis experiments and absorption titration; 3a and 4 a bind G-quadruplex DNA with binding constants (K) of approximately 106-107dm 3mol-1, which are at least an order of magnitude higher than the K values for duplex DNA. NMR spectroscopic titration experiments and molecular modeling showed that 4 a binds c-myc G-quadruplex DNA through an external end-stacking mode at the 3'terminal face of the G-quadruplex. Intriguingly, binding of c-myc G-quadruplex DNA by 3b is accompanied by an increase of up to 38-fold in photoluminescence intensity at λmax = 622 nm. © 2010 Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim. | ||||||||
Persistent Identifier | http://hdl.handle.net/10722/142059 | ||||||||
ISSN | 2023 Impact Factor: 3.9 2023 SCImago Journal Rankings: 1.058 | ||||||||
ISI Accession Number ID |
Funding Information: We are grateful for financial support from The University of Hong Kong (University Development Fund), the Hong Kong Research Grant Council (HKU 7052/07P), and the Areas of Excellence Scheme established under the University Grants Committee of the Hong Kong Special Administrative Region, China (AoE/P-10/01). | ||||||||
References | |||||||||
Grants |
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Wang, P | en_HK |
dc.contributor.author | Leung, CH | en_HK |
dc.contributor.author | Ma, DL | en_HK |
dc.contributor.author | Yan, SC | en_HK |
dc.contributor.author | Che, CM | en_HK |
dc.date.accessioned | 2011-10-17T08:10:32Z | - |
dc.date.available | 2011-10-17T08:10:32Z | - |
dc.date.issued | 2010 | en_HK |
dc.identifier.citation | Chemistry - A European Journal, 2010, v. 16 n. 23, p. 6900-6911 | en_HK |
dc.identifier.issn | 0947-6539 | en_HK |
dc.identifier.uri | http://hdl.handle.net/10722/142059 | - |
dc.description.abstract | A series of platinum(II) complexes with tridentate ligands was synthesized and their interactions with Gquadruplex DNA within the c-myc gene promoter were evaluated. Complex 1, which has a flat planar 2,6-bis(benzimidazol-2-yl)pyridine (bzimpy) scaffold, was found to stabilize the c-myc G-quadruplex structure in a cellfree system. An in silico G-quadruplex DNA model has been constructed for structure-based virtual screening to develop new PtII-based complexes with superior inhibitory activities. By using complex 1 as the initial structure for hit-to-lead optimization, bzimpy and related 2,6-bis(pyrazol-3-yl) pyridine (dPzPy) scaffolds containing amine side-chains emerge as the top candidates. Six of the top-scoring complexes were synthesized and their interactions with c-myc G-quadruplex DNA have been investigated. The results revealed that all of the complexes have the ability to stabilize the c-myc G-quadruplex. Complex 3a ([PtIIL2R]+; L2 = 2,6bis[1-(3-piperidinepropyl)-1H-enzo[d]imidazol-2-yl]pyridine, R = Cl) displayed the strongest inhibition in a cell-free system (IC50 = 2.2 μM) and was 3.3-fold more potent than that of 1. Complexes 3a and 4a ([PtIIL3R]+; L3 = 2,6-bis[1-(3-morpholinopropyl)1H- pyrazol-3-yl]pyridine, R = Cl) were found to effectively inhibit c-myc gene expression in human hepatocarcinoma cells with IC50 values of 17 μM, whereas initial hit 1 displayed no significant effect on gene expression at concentrations up to 50 μM. Complexes 3a and 4a have a strong preference for Gquadruplex DNA over duplex DNA, as revealed by competition dialysis experiments and absorption titration; 3a and 4 a bind G-quadruplex DNA with binding constants (K) of approximately 106-107dm 3mol-1, which are at least an order of magnitude higher than the K values for duplex DNA. NMR spectroscopic titration experiments and molecular modeling showed that 4 a binds c-myc G-quadruplex DNA through an external end-stacking mode at the 3'terminal face of the G-quadruplex. Intriguingly, binding of c-myc G-quadruplex DNA by 3b is accompanied by an increase of up to 38-fold in photoluminescence intensity at λmax = 622 nm. © 2010 Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim. | en_HK |
dc.language | eng | - |
dc.publisher | Wiley - V C H Verlag GmbH & Co KGaA. The Journal's web site is located at http://www.wiley-vch.de/home/chemistry | en_HK |
dc.relation.ispartof | Chemistry - A European Journal | en_HK |
dc.subject | DNA structures | en_HK |
dc.subject | Gquadruplexes | en_HK |
dc.subject | Ligand effects | en_HK |
dc.subject | Oncogenes | en_HK |
dc.subject | Platinum | en_HK |
dc.subject.mesh | DNA - chemistry | - |
dc.subject.mesh | Down-Regulation - drug effects | - |
dc.subject.mesh | G-Quadruplexes - drug effects | - |
dc.subject.mesh | Organoplatinum Compounds - chemical synthesis - chemistry - pharmacology | - |
dc.subject.mesh | Proto-Oncogene Proteins c-myc - chemistry - drug effects | - |
dc.title | Structure-based design of platinum(II) Complexes as c-myc oncogene Down-regulators and luminescent probes for G-quadruplex DNA | en_HK |
dc.type | Article | en_HK |
dc.identifier.openurl | http://library.hku.hk:4550/resserv?sid=HKU:IR&issn=0947-6539&volume=16&issue=23&spage=6900&epage=6911&date=2010&atitle=Structure-based+design+of+platinum(II)+complexes+as+c-myc+oncogene+down-regulators+and+luminescent+probes+for+G-quadruplex+DNA | - |
dc.identifier.email | Leung, CH:duncanl@hkucc.hku.hk | en_HK |
dc.identifier.email | Ma, DL:edmondma@hku.hk | en_HK |
dc.identifier.email | Che, CM:cmche@hku.hk | en_HK |
dc.identifier.authority | Leung, CH=rp00730 | en_HK |
dc.identifier.authority | Ma, DL=rp00760 | en_HK |
dc.identifier.authority | Che, CM=rp00670 | en_HK |
dc.description.nature | link_to_subscribed_fulltext | - |
dc.identifier.doi | 10.1002/chem.201000167 | en_HK |
dc.identifier.pmid | 20437426 | - |
dc.identifier.scopus | eid_2-s2.0-77953563443 | en_HK |
dc.identifier.hkuros | 181303 | - |
dc.relation.references | http://www.scopus.com/mlt/select.url?eid=2-s2.0-77953563443&selection=ref&src=s&origin=recordpage | en_HK |
dc.identifier.volume | 16 | en_HK |
dc.identifier.issue | 23 | en_HK |
dc.identifier.spage | 6900 | en_HK |
dc.identifier.epage | 6911 | en_HK |
dc.identifier.isi | WOS:000279856100023 | - |
dc.publisher.place | Germany | en_HK |
dc.relation.project | Institute of molecular technology for drug discovery and synthesis | - |
dc.identifier.scopusauthorid | Wang, P=7405460611 | en_HK |
dc.identifier.scopusauthorid | Leung, CH=7402612570 | en_HK |
dc.identifier.scopusauthorid | Ma, DL=7402075538 | en_HK |
dc.identifier.scopusauthorid | Yan, SC=7401744858 | en_HK |
dc.identifier.scopusauthorid | Che, CM=7102442791 | en_HK |
dc.identifier.citeulike | 7123850 | - |
dc.identifier.issnl | 0947-6539 | - |